Considerations in grading a recommendation methodological quality of evidencemethodological quality of evidence likelihood of biaslikelihood of bias trade-off.

Slides:



Advertisements
Similar presentations
Holger Schünemann, MD, PhD From Evidence to EMS Practice: Building the National Model Washington, September 4,
Advertisements

The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
A systematic review of interventions for children with cerebral palsy: state of the evidence Rohini R Rattihalli
Dallas : CPAP and IPPV In spontaneously breathing preterm infants with respiratory distress requiring respiratory support in the delivery room,
The Science of Guidelines The 7th ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines Holger Schünemann, MD, PhD Italian.
Chicago 2014 Peter Morley, Eddy Lang E3, GRADE expert Incorporating lower levels of evidence.
Critically Evaluating the Evidence: Tools for Appraisal Elizabeth A. Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management Assistant.
Summarising findings about the likely impacts of options Judgements about the quality of evidence Preparing summary of findings tables Plain language summaries.
Grading of Recommendations Assessment, Development and Evaluation (GRADE) Methodology.
Introduction to Critical Appraisal : Quantitative Research
Selecting Research Participant 1. Sample & Population A population is the entire set of individuals of interest to a researcher. A sample is a set of.
Journal Club Alcohol and Health: Current Evidence September–October 2004.
Clinical Trials Hanyan Yang
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI #261 EVREV 2: Daniel Pichel COI #513 Taskforce: ACS ACS 873: Pre-hospital STEMI Activation.
Journal Club Alcohol and Health: Current Evidence January–February 2007.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Critical Appraisal of an Article on Therapy (2). Formulate Clinical Question Patient/ population Intervention Comparison Outcome (s) Women with IBS Alosetron.
NKF-KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease UPDATE OF HEMOGLOBIN TARGET Am.J.Kidney.Dis.
Dallas 2015 TFQO: EVREVs: Aaron Donoghue / Jonathan Duff Taskforce: EIT Teaching Compression-Only CPR.
Illustrating the GRADE Methodology: The Cather Associated-UTI Case Study TEACH Level II Workshop 5 NYAM August 9 th, 2013 Craig A Umscheid, MD, MSCE, FACP.
Grading of Recommendations Assessment, Development, and Evaluation (GRADE) Working Group
Renal Replacement Therapy in Critical Illness Silverstar 2005 Jim Kutsogiannis Terry Paul Zoheir Bshouty.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 14 Screening and Prevention of Illnesses and Injuries: Research Methods.
Acute Bacterial Rhinosinusitis. Brief Background Typically follows viral infection Dx is by clinical manifestations Streptococcus pneumoniae, Haemophilus.
Brief summary of the GRADE framework Holger Schünemann, MD, PhD Chair and Professor, Department of Clinical Epidemiology & Biostatistics Professor of Medicine.
EVIDENCE BASED MEDICINE Effectiveness of therapy Ross Lawrenson.
SIGN Non-Pharmaceutical Management of Depression in Adults Recommendations.
Julio A. Ramirez, MD, FACP Professor of Medicine Chief, Infectious Diseases Division, University of Louisville Chief, Infectious Diseases Section, Veterans.
Grading Strength of Evidence Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Systematic Reviews Methods Guide.
CAT 3 Harm, Causation Maribeth Chitkara, MD Rachel Boykan, MD.
EBCP. Random vs Systemic error Random error: errors in measurement that lead to measured values being inconsistent when repeated measures are taken. Ie:
Plan GRADE backgroundGRADE background confidence in estimates (quality of evidence)confidence in estimates (quality of evidence) evidence profilesevidence.
VSM CHAPTER 6: HARM Evidence-Based Medicine How to Practice and Teach EMB.
Why Grade the Evidence? target audience for Cochrane reviewstarget audience for Cochrane reviews –clinicians interested in the question –policy makers,
Two questions in grading recommendations Are you sure?Are you sure? –Yes: Grade 1 –No: Grade 2 What is the methodological quality of the underlying evidenceWhat.
Wipanee Phupakdi, MD September 15, Overview  Define EBM  Learn steps in EBM process  Identify parts of a well-built clinical question  Discuss.
Dallas 2015 TFQO: Name and #COI EVREV 1: Name and #COI Taskforce: Name Insert Short PICO title (including unique PICO ID#) Total of 4 (maximum) using standard.
Why Grade Recommendations? strong recommendationsstrong recommendations –strong methods –large precise effect –few down sides of therapy weak recommendationsweak.
Study designs. Kate O’Donnell General Practice & Primary Care.
Objectives  Identify the key elements of a good randomised controlled study  To clarify the process of meta analysis and developing a systematic review.
WHO GUIDANCE FOR THE DEVELOPMENT OF EVIDENCE-BASED VACCINE RELATED RECOMMENDATIONS August 2011.
1 Study Design Issues and Considerations in HUS Trials Yan Wang, Ph.D. Statistical Reviewer Division of Biometrics IV OB/OTS/CDER/FDA April 12, 2007.
Dallas 2015 TFQO: Allan de Caen COI #38 EVREV 1: Tia Raymond COI #153; EVREV 2: Jonathan Egan COI #44 Taskforce: Peds The role of invasive vascular monitoring.
Anne Matthews, Health & Society, School of Nursing and Human Sciences, DCU The paradox of ‘low quality evidence; strong recommendation’: An analysis of.
This material was developed by Oregon Health & Science University, funded by the Department of Health and Human Services, Office of the National Coordinator.
Dallas 2015 TFQO: Vinay Nadkarni #375 EVREV 1: Vinay Nadkarni #375 EVREV 1: Dave Kloeck #126 Taskforce: Paeds Paed 424: Vasopressors in Paediatric cardiac.
Finding, Evaluating, and Presenting Evidence Sharon E. Lock, PhD, ARNP NUR 603 Spring, 2001.
Why Grade Recommendations? strong recommendationsstrong recommendations –strong methods –large precise effect –few down sides of therapy weak recommendationsweak.
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
Vanderbilt Sports Medicine Evidence-Base Medicine How to Practice and Teach EBM Chapter 5 : Therapy.
G. Biondi Zoccai – Ricerca in cardiologia What to expect? Core modules IntroductionIntroduction Finding out relevant literatureFinding out relevant literature.
Dallas 2015 TFQO: Koen Monsieurs 372 EVREV 1: Koen Monsieurs 372 EVREV 2: Ahamed Idris 349 Taskforce: BLS BLS366 Chest Compression Depth (adults)
The New York Academy of Medicine Teaching Evidence Assimilation for Collaborative Healthcare New York, August 8, 2012 Yngve Falck-Ytter, MD, AGAF for the.
GDG Meeting Wednesday November 9, :30 – 11:30 am.
بسم الله الرحمن الرحیم.
Why Grade Recommendations? strong recommendationsstrong recommendations –strong methods –large precise effect –few down sides of therapy weak recommendationsweak.
Dallas 2015 TFQO: Name EVREVs: Names and #COI Taskforce: Name Insert Short PICO title Total of 12 (no studies) to 20 slides (maximum) using standard format.
Chicago 2014 TFQO: Clifton Callaway # EVREV 1: Janice Zimmerman # EVREV 2: Jonathan Sullivan COI # Taskforce: ALS ALS 790 : Induced Hypothermia.
GRADE Grading of Recommendations Assessment, Development and Evaluation British Association of Dermatologists April 2014.
CRITICAL APPARAISAL OF A PAPER ON THERAPY 421 CORSE EVIDENCE BASED MEDICINE (EBM)
Why this talk? you will be seeing a lot of GRADE
Conflicts of interest Major role in development of GRADE
Overview of the GRADE approach – selected slides
Selecting Research Participant
Summary of Findings tables in Cochrane reviews
Plan GRADE background two steps evidence profiles
Noninvasive Positive-Pressure Ventilation In COPD
Systematic Reviews and Meta-Analysis -Part 2-
Presentation transcript:

Considerations in grading a recommendation methodological quality of evidencemethodological quality of evidence likelihood of biaslikelihood of bias trade-off between benefits and riskstrade-off between benefits and risks

Methodological quality specific to an outcome benefitsbenefits –often have RCTS risksrisks –often limited to observational studies

Possible levels of quality strongstrong intermediateintermediate weakweak very weakvery weak

Quality of evidence, Where to start? basic study designbasic study design randomized trialsrandomized trials –strong evidence observational studiesobservational studies –weak evidence

Downgrading quality, weak implementation detailed design and executiondetailed design and execution –concealment –balance in known prognostic factors –intention to treat principle observed –blinding –completeness of follow-up

Downgrading quality inconsistency evidence weaker if results differ from study to studyevidence weaker if results differ from study to study subjective judgementsubjective judgement –you will be told

Downgrading quality, indirectness indirect treatment comparisonsindirect treatment comparisons –interested in A versus B –have A versus C and B versus C different patient populationdifferent patient population different interventiondifferent intervention different outcomedifferent outcome

Downgrading quality, reporting bias, sparse data what if you have a biased sample of studies?what if you have a biased sample of studies? publication biaspublication bias what if one study with 10 people?what if one study with 10 people?

What can increase strength of evidence? large association can upgradelarge association can upgrade –very large, 2 levels –large with no plausible confounders, 1 level dose-response gradientdose-response gradient –can upgrade one level

Grade of Recommendations do it or don’t do itdo it or don’t do it –strong recommendation probably do it, or probably don’tprobably do it, or probably don’t –weaker recommendation

Risk/Benefit tradeoff seriousness of outcomeseriousness of outcome magnitude of effectmagnitude of effect precision of treatment effectprecision of treatment effect risk of target eventrisk of target event risk of adverse eventsrisk of adverse events cost of therapycost of therapy values and preferencesvalues and preferences